Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 38Neoplasm Metastasis 14Liver Neoplasms 11Colorectal Neoplasms 11Cholangiocarcinoma 9Pancreatic Neoplasms 8Lung Neoplasms 8Colonic Neoplasms 7Breast Neoplasms 7Thyroid Nodule 6Recurrence 6Carcinoma, Renal Cell 6Carcinoma, Non-Small-Cell Lung 6Thyroid Neoplasms 5Rectal Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Prostatic Neoplasms 3Pain 3Kidney Neoplasms 3Barrett Esophagus 3Agnosia 3Thyroid Diseases 2Thyroid Cancer, Papillary 2Leiomyoma 2Hyperaldosteronism 2Gallbladder Neoplasms 2Cancer Pain 2Bile Duct Neoplasms 2Adrenocortical Adenoma 2

Interventions

regorafenib 2Radiofrequency Ablation 1Nivolumab 1Irinotecan 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Colorectal Cancer Liver Metastases × Radiofrequency Ablation × Clear all
NCT05485909 2022-08-03

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Sun Yat-sen University

Phase 2 Unknown
32 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡